Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

FFR to guide treatment of secondary vessel on bifurcations

Original title: Randomized Comparison of FFR-Guided and Angiography-Guided Provisional Stenting of True Coronary Bifurcation Lesions The DKCRUSH-VI (Double Kissing Crush Versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions VI) Trial. Reference: Shao-Liang Chen et al. J Am Coll Cardiol Intv. 2015. Online before print.

Angiography for guiding the need to implant a stent in the side branch of a bifurcation after stent implantation in the main vessel has been successful for most injuries. Still standby a study about whether measurement of fractional flow reserve (FFR) could be superior to conventional angiography for guiding strategy of provisional stent. 

The study included a total of 320 patients with bifurcation lesions (Medina 1, 1, 1 or 0, 1, 1) and a provisional stent strategy; randomized (1: 1) to angiography versus FFR to guide when stent implantation is necessary in the side branch. In the group guided by angiography a stent was implanted in the secondary vessel when after stent implantation in the main vessel TIMI flow <3, ostial lesion >70% or type A dissection. In the other group a stent was implanted in the side branch if after stent implantation in the main vessel measured of FFR was <0.8 in the accessory vessel. The primary end point was a composite of major adverse cardiac events (cardiac death, myocardial infarction and ischemia-driven TVR) at one year.

 Treatment of secondary branch (balloon or stent) was performed in 63.1% of angiography group and 56.3% of the FFR group (p = 0.07) and a stent was implanted in 38.1% of group guided by angiography versus 25.9 % of FFR group (p = 0.01). When an attempt was made, we were able to successfully implant the stent in 83.6% of angiography group and 73.3% of the FFR group (p = 0.01). The combined of major cardiac events at one year, was identical in both groups (18.1% for both; p = 1). The rates of revascularization and stent thrombosis were 6.9% versus 5.6% (p = 0.82) and 1.3% versus 0.6% (p = 0.56) for the angiographic group and the FFR-guided group respectively.

Conclusion

In this multicenter, randomized trial, angiography and FFR were similar to guide the strategy of provisional stent in bifurcations.

Editorial comment

Again in bifurcations less is more and the strategy of provisional stent seems that it cannot be improved. Although the study included relatively few patients, the FFR did not even show a good turn tendency.

SOLACI

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...

GLUCO-TAVI | Can Glucocorticoids Reduce the Need for Permanent Pacemaker Implantation After TAVI?

Despite the expansion of transcatheter aortic valve implantation (TAVI) indications, cardiac conduction disturbances (CCD) and the need for permanent pacemaker implantation (PPI) remain the...